本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apogee Therapeutics

33.11
+1.073.34%
盤後33.00-0.1100-0.33%17:11 EDT
成交量:34.80萬
成交額:1,133.64萬
市值:19.23億
市盈率:-10.03
高:33.38
開:32.08
低:31.60
收:32.04
資料載入中...
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

重要事件披露

Form 8-K - Current report
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]